Ensysce Net Tangible Assets from 2010 to 2026
| ENSC Stock | USD 0.44 0.17 27.87% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter -7.1 M | Current Value -6.7 M | Quarterly Volatility 103 M |
Check Ensysce Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ensysce Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 373.2 K, Interest Income of 1.1 M or Interest Expense of 1.6 M, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 16.31 or PTB Ratio of 3.62. Ensysce financial statements analysis is a perfect complement when working with Ensysce Biosciences Valuation or Volatility modules.
Ensysce | Net Tangible Assets | Build AI portfolio with Ensysce Stock |
Analyzing Ensysce Biosciences's Net Tangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Tangible Assets has evolved provides context for assessing Ensysce Biosciences's current valuation and future prospects.
Latest Ensysce Biosciences' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Ensysce Biosciences over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Ensysce Biosciences' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ensysce Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Ensysce Net Tangible Assets Regression Statistics
| Arithmetic Mean | 112,715,128 | |
| Coefficient Of Variation | 91.37 | |
| Mean Deviation | 98,300,264 | |
| Median | 197,392,105 | |
| Standard Deviation | 102,986,416 | |
| Sample Variance | 10606.2T | |
| Range | 205.3M | |
| R-Value | (0.86) | |
| Mean Square Error | 2918.6T | |
| R-Squared | 0.74 | |
| Slope | (17,567,852) | |
| Total Sum of Squares | 169699.2T |
Ensysce Net Tangible Assets History
About Ensysce Biosciences Financial Statements
Ensysce Biosciences stakeholders use historical fundamental indicators, such as Ensysce Biosciences' Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Ensysce Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ensysce Biosciences' assets and liabilities are reflected in the revenues and expenses on Ensysce Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ensysce Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | -7.1 M | -6.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:Check out the analysis of Ensysce Biosciences Correlation against competitors. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Will Biotechnology sector continue expanding? Could Ensysce diversify its offerings? Factors like these will boost the valuation of Ensysce Biosciences. Projected growth potential of Ensysce fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ensysce Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.35) | Revenue Per Share | Quarterly Revenue Growth (0.86) | Return On Assets | Return On Equity |
Investors evaluate Ensysce Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ensysce Biosciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ensysce Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Ensysce Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ensysce Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ensysce Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.